| Neoadjuvant chemotherapy cannot be regarded as adequate routine therapy strategy of advanced ovarian cancer. | |
| | |
MedLine Citation:
|
PMID: 22274314 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
ABSTRACT: Minority vote to statement A5 of the Fourth Ovarian Cancer Consensus Conference, Vancouver 2010, on behalf of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Germany plus North-Eastern Society of Gyneco-Oncology and the AGO Austria. |
| | |
Authors:
|
Andreas du Bois; Christian Marth; Jacobus Pfisterer; Philipp Harter; Felix Hilpert; Alain G Zeimet; Jalid Sehouli |
Related Documents
:
|
17167974 - Effect of immunotherapy and spleen preservation on immunological function in patients w... 20952724 - Review. colon cancer vaccines: an update. 12946654 - Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? 14967074 - Future directions: oncolytic viruses. 21663394 - A novel bioluminescence orthotopic mouse model for advanced lung cancer. 12496764 - Fingerprinting the circulating repertoire of antibodies from cancer patients. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society Volume: 22 ISSN: 1525-1438 ISO Abbreviation: Int. J. Gynecol. Cancer Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-01-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9111626 Medline TA: Int J Gynecol Cancer Country: United States |
Other Details:
|
Languages: eng Pagination: 182-5 Citation Subset: IM |
Affiliation:
|
*Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Studiengruppe, Germany; and †Arbeitsgemeinschaft Gynaekologische Onkologie, Austria. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The Option of HBIG-Free Prophylaxis Against Recurrent HBV.
Next Document: Association of interleukin 16 with the development of ovarian tumor and tumor-associated neoangiogen...